"Contango, which has funds under management in excess of $600m, plans to join the Australian bourse through a backdoor listing via biotech minnow Tyrian Diagnostics." This is a NO Brainer !
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game